Antimutagenic, Antigenotoxic, and Anticytotoxic Activities of Silybum Marianum [L.] Gaertn Assessed by the Salmonella Mutagenicity Assay (Ames Test) and the Micronucleus Test in Mice Bone Marrow

References

• Gurib-Fakim A: Medicinal plants: Traditions of yesterday and drugs of tomorrow. Mol Aspects Med 27, 1–93, 2006.
   PubMedGoogle Scholar
• Svobodová A, Zdařilová A, Mališková J, Mikulková H, Walterová D, et al.: Attenuation of UVA-induced damage to human keratinocytes by silymarin. J Dermatol Sci 46, 21–30, 2007.
   PubMed Web of Science ®Google Scholar
• Su CH, Chen LJ, Liao JF, Cheng JT: Increase of phosphatase and tensin homolog by silymarin to inhibit human pharynx squamous cancer. J Med Food 16, 778–784, 2013.
   PubMed Web of Science ®Google Scholar
• Kaur M and Agarwal R: Silymarin and epithelial cancer chemoprevention: How close we are to bedside? Toxicol Appl Pharmacol 224, 350–359, 2007.
   PubMed Web of Science ®Google Scholar
• Fraschini F, Demartini G, and Esposti D: Pharmacology of silymarin. Clin Drug Invest 22, 51–65, 2002.
   Web of Science ®Google Scholar
• Kren V and Walterová D: Silybin and silymarin-new effects and applications. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 149, 29–41, 2005.
   PubMedGoogle Scholar
• Afaq F, Adhami VM, Ahmad N, and Mukhtar H: Botanical antioxidants for chemoprevention of photocarcinogenesis. Front Biosci 7, 784–792, 2002.
   Web of Science ®Google Scholar
• Ramasamy K and Agarwal R: Multitargeted therapy of cancer by silymarin. Cancer Lett 269, 352–362, 2008.
   PubMed Web of Science ®Google Scholar
• Lee JI, Narayan M, and Barrett JS: Analysis and comparison of active constituents in commercial standardized silymarin extracts by liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr 845, 95–103, 2007.
   Web of Science ®Google Scholar
• Kvasnička F, Bíba B, Ševčık R, Voldřich M, and Krátká J: Analysis of the active components of silymarin. J Chromatogr A 990, 239–245, 2003.
   PubMed Web of Science ®Google Scholar
• Saller R, Meier R, and Brignoli R: The use of silymarin in the treatment of liver diseases. Drugs 61, 2035–2063, 2001.
   PubMed Web of Science ®Google Scholar
• Lee DY and Liu Y: Molecular structure and stereochemistry of silybin A, silybin B, isosilybin A, and isosilybin B, Isolated from Silybum marianum (milk thistle). J Nat Prod 66, 1171–1174, 2003.
   PubMed Web of Science ®Google Scholar
• Maron DM and Ames BN: Revised methods for the Salmonella mutagenicity test. Mutat Res 113, 173–215, 1983.
   PubMed Web of Science ®Google Scholar
• Sghaier MB, Bhouri W, Bouhlel I, Skandrani I, Boubaker J, et al.: Inhibitory effect of Teucrium ramosissimum extracts on aflatoxin B1, benzo[a]pyrene, 4-nitro-o-phenylenediamine and sodium azide induced mutagenicity: Correlation with antioxidant activity. S Afr J Bot 77, 730–740, 2011.
   Web of Science ®Google Scholar
• Casas-Grajales S and Muriel P: Antioxidants in liver health. World J Gastrointest Pharmacol Ther 6, 59–72, 2015.
   PubMedGoogle Scholar
• Schmid W: The micronucleus test for cytogenetic analysis. In: Chemical Mutagens: Principles and Methods for their Detection, Hollaender A (ed.). New York: Plenum Press, 1976, v. 4, pp. 31–53.
   Google Scholar
• Mortelmans K and Zeiger E: The Ames Salmonella/microsome mutagenicity assay. Mutat Res Fundam Mol Mech Mutagen 455, 29–60, 2000.
   PubMed Web of Science ®Google Scholar
• Barnes W, Tuley E, and Eisenstadt E: Base-sequence analysis of His+ revertants of the hisG46 missense mutation in Salmonella typhimurium. Environ Mutagen 4, 297, 1982 (abstr), Thirteenth Annual Meeting of the Environmental Mutagen Society.
   Google Scholar
• Bode AM and Dong Z: Signal transduction pathways: targets for chemoprevention of skin cancer. Lancet Oncol 1, 181–188, 2000.
   PubMedGoogle Scholar
• Dearfield KL, Cimino MC, McCarroll NE, Mauer I, and Valcovic LR: Genotoxicity risk assessment: a proposed classification strategy. Mutat Res Genet Toxicol Environ Mutagen 521, 121–135, 2002.
   PubMed Web of Science ®Google Scholar
• Suzuki Y, Takagi R, Kawasaki I, Matsudaira T., Yanagisawa H, et al.: The micronucleus test and erythropoiesis: Effects of cyclic adenosine monophosphate (cAMP) on micronucleus formation. Mutat Res Genet Toxicol Environ Mutagen 655, 47–51, 2008.
   PubMed Web of Science ®Google Scholar
• Fenech M: Biomarkers of genetic damage for cancer epidemiology. Toxicology 181–182, 411–416, 2002.
   PubMed Web of Science ®Google Scholar
• Kirkland D, Reeve L, Gatehouse D, and Vanparys P: A core in vitro genotoxicity battery comprising the Ames test plus the in vitro micronucleus test is sufficient to detect rodent carcinogens and in vivo genotoxins. Mutat Res Genet Toxicol Environ Mutagen 721, 27–73, 2011.
   PubMed Web of Science ®Google Scholar
• Chlopčíková S, Psotová J, Miketová P, and Šimánek V: Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans. Phytother Res 18, 107–110, 2004.
   PubMed Web of Science ®Google Scholar
• Pietrangelo A, Borella F, Casalgrandi G, Montosi G, Ceccarelli D, et al.: Antioxidant activity of silybin in vivo during long-term iron overload in rats. Gastroenterology 109, 1941–1949, 1995.
   PubMed Web of Science ®Google Scholar
• Zhao J, Lahiri-Chatterjee M, Sharma Y, and Agarwal R: Inhibitory effect of a flavonoid antioxidant silymarin on benzoyl peroxide-induced tumor promotion, oxidative stress and inflammatory responses in SENCAR mouse skin. Carcinogenesis 21, 811–816, 2000.
   PubMed Web of Science ®Google Scholar
• Trouillas P, Marsal P, Svobodová A, Vostálová J, Gazák R, et al.: Mechanism of the antioxidant action of silybin and 2,3-dehydrosilybin flavonolignans: a joint experimental and theoretical study. J Phys Chem A 112, 1054–1063, 2008.
   PubMed Web of Science ®Google Scholar
• Dhanalakshmi S, Mallikarjuna GU, Singh RP, and Agarwal R: Silibinin prevents ultraviolet radiation-caused skin damages in SKH-1 hairless mice via a decrease in thymine dimer positive cells and an up-regulation of p53-p21/Cip1 in epidermis. Carcinogenesis 25, 1459–1465, 2004.
   PubMed Web of Science ®Google Scholar
• Friedberg EC: How nucleotide excision repair protects against cancer. Nat Rev Cancer 1, 22–33, 2001.
   PubMed Web of Science ®Google Scholar
• Basiglio CL, Sánchez Pozzi EJ, Mottino AD, and Roma MG: Differential effects of silymarin and its active component silibinin on plasma membrane stability and hepatocellular lysis. Chem Biol Interact 179, 297–303, 2009.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Agarwal C, Ichikawa H, Singh RP, and Aggarwal BB: Anticancer potential of silymarin: from bench to bed side. Anticancer Res 26, 4457–4498, 2006.
   PubMed Web of Science ®Google Scholar
• Deep G and Agarwal R: Chemopreventive efficacy of silymarin in skin and prostate cancer. Integr Cancer Ther 6, 130–145, 2007.
   PubMed Web of Science ®Google Scholar
• Singh RP and Agarwal R: Cancer chemopreventive agent silibinin, targets mitogenic and survival signaling in prostate cancer. Mutat Res 555, 21–32, 2004.
   PubMed Web of Science ®Google Scholar
• Walle T: Absorption and metabolism of flavonoids. Free Radic Biol Med 36, 7, 829–837, 2004.
   PubMed Web of Science ®Google Scholar